If you're Reading This, There's Still Time
Figuring out how to generate enough energy to power AI will be one of our country's biggest problems - but one man believes "we'll be able to do it" thanks to this energy company.
Shares Stats
| Shares Outstanding | 2,035,000,000 |
| Shares Float | 2,034,280,000 |
| Shares Short | 26,340,000 |
| Insider Holdings | 7% |
| Institution Holdings | 82.78% |
About Bristol-Myers Squibb Co
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
General
| Name | Bristol-Myers Squibb Co |
| Ticker | BMY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 34,100 |
Highlights
| Analyst Target | 52.40 |
| Market Cap | 88,470,200,000 |
| PE Ratio | 17.54 |
| PEG Ratio | 2.26 |
| EBITDA | 19,114,999,808 |
Financials
| Curr Year EPS Estimate | 6.45 |
| Next Quarter EPS Estimate | 1.69 |
| Profit Margin | 10.58% |
| Operating Margin | 26.11 |
| Return on Assets | 0.08 |
| Return on Equity | 0.29 |
| Revenue | 47.7B |
| Earnings Per Share | 2.49 |
| Revenue Per Share | 23.49 |
| Gross Profit | 35,262,001,152 |
| Quarterly Revenue Growth | 0.01 |
Valuation
| Trailing PE | 17.59 |
| Forward PE | 7.58 |
| Price/Sales (Trailing 12 Mt.) | 1.87 |
| Price/Book (Most Recent Quarter) | 5.34 |
Dividend
Bristol-Myers Squibb Co pays out a dividend of $2.47 per share, with a dividend yield of 5.69%.
BMY's next dividend payment will be made to shareholders on November 3, 2025.
They pay out 0.00% of their earnings out as a dividend.
Recent Dividends
| Nov 3, 2025 | $0.62 |
| Aug 1, 2025 | $0.62 |
| May 1, 2025 | $0.62 |
| Feb 3, 2025 | $0.62 |
| Nov 1, 2024 | $0.60 |
| Aug 1, 2024 | $0.60 |
| May 1, 2024 | $0.60 |
| Feb 1, 2024 | $0.60 |
Cathie Wood, Tom Lee Align On These 10 Stock Picks: Some Might Surprise You
A new ETF from Tom Lee shares 10 stocks in common with Cathie Wood's Ark Funds. A look at the stocks both well-known financial figures like.
Dave Ramsey Doesn't Mess Around With Bitcoin Or Gold, Says 'I Have Three Investments' — Here's What They Are
Personal finance expert Dave Ramsey has long dismissed crypto, gold and single-stock investing, calling them risky distractions — but new research shows that his disciplined mutual fund approach may have cost him market-beating returns.
Forget Tesla - This Is the Real Play - Ad
Elon just dropped $1B into Tesla shares. But the real money could be in his potential October 23 AI launch - and it's not Tesla.
Mark Cuban Shares His Top Strategies for Protecting Wealth After Hitting Millionaire Status
Mark Cuban once disclosed his strategies for preserving wealth after becoming a millionaire. These insights could be beneficial for anyone aiming to secure their financial future.
Trump Ally Laura Loomer Turns on Him Over Qatar Military Base Plan, Calls It a 'Betrayal'
Laura Loomer, a staunch supporter of President Donald Trump, has voiced her dissatisfaction with the president's decision to permit a Qatari air force facility in Idaho.
Could $1 Stock Be Sitting on a Billion-Dollar Discovery? - Ad
This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.
Billionaire Makes $72 Million On Trilogy Metals Stock—Here's What Else He's Holding
Billionaire hedge fund manager John Paulson has scored extraordinary gains with Trilogy Metals—he's also holding gold miners.
Cracker Barrel Co-Founder Blasts CEO For $700 Million Rebranding Failure And Knowing 'Very Little' About Brand's Roots: 'Taco Bell Is Not...'
The co-founder of Cracker Barrel Old Country Store Inc. (NASDAQ: CBRL), Tommy Lowe, has publicly criticized the company's CEO, Julie Felss Masino, for being disconnected from the brand's core values and its loyal customer base.
Never Sell the Next Mag 7 Stocks! - Ad
A new set of 7 AI stocks are dominating the market. Here's why one financial guru says they could be the most famous companies in the world by 2030.
Trump's Genius Act Has Changed Global Monetary System, Says Economist: Stablecoins Will Usher In 'Hyperinflation'
Lynett Zang issued a stark warning about the future of the dollar, monetary stability, pointing to the implications of Trump's "Genius Act".
Retail Investors Gain Access To Private Credit Market Via This New ETF
Simplify Asset Management and VettaFi have introduced a new exchange-traded fund (ETF) that enables retail investors to tap into the rapidly growing private credit market.
Trump's Backing Oil. Nvidia's Powering A.I. - Ad
There's a new kind of power play happening in the Middle East. Trump helped broker it. Nvidia's chips are driving it. Saudi money is funding it. But here's what the media missed: A tiny U.S. energy company could be the biggest winner of the A.I. + energy boom. You can still get in before the floodgates open.
Shutdown Impact: Americans Are Delaying Big Purchases, But Not As Many As You Think
Government shutdowns have increased since 1976, but markets remain stable. However, 17% of Americans delay major purchases during shutdowns.
Demand For Electric Pickup Trucks Soar In Q3, Except If You're Tesla
New data shows the top-selling EV brands and companies for the U.S. in the third quarter. Strong demand for electric pickup trucks benefits several companies.
Are you a long-term investor? You'll Want to Hear This - Ad
The President of the United States once went to bat for an American energy company that's merging energy and AI. It's wildly cheap, and one man believes it could be the long-term answer to our AI energy needs.
Elizabeth Warren Says Trump Is 'Plotting' To Reduce Social Security Benefits For Older Americans: 'We Must Call It Out And Stop These Cuts'
Sen. Warren accuses Trump of planning to cut Social Security benefits for older Americans, citing a report and ongoing debate. Trump denies it.
How To Earn $500 A Month From JPMorgan Stock Ahead Of Q3 Earnings
JPMorgan (NYSE:JPM) will release Q3 earnings on Oct. 14. Analysts expect $4.86 EPS and $45.42B revenue. Dividend yield currently at 1.96%.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
Silver Nears $50 Amid Inventory Crisis, Outpacing Gold
Silver prices closed last week at multi-year highs, coming within reach of their 2011 peak of $49.95 per ounce.
Hungary's Orbán tells Trump that dropping Russian energy would bring economy 'to its knees'
BUDAPEST, Hungary (AP) — Hungarian Prime Minister Viktor Orbán said Friday that Hungary will continue to source fossil fuels from Russia despite demands from his ally U.S. President Donald Trump, and that he'd informed the president that dropping Russian energy would be a “disaster” for Hungary's economy.
Central Banks Demand More Gold - This $1 Firm Could Supply It - Ad
This tiny company is currently sitting on one of America's largest deposits of gold... land that was hidden away from the public for over 60 years. With Central Banks demanding gold to combat inflation - miners like this one show huge potential for investors
AST SpaceMobile Stock Surges After Hours Amid BlueBird Satellite Production Update
AST SpaceMobile's stock surged 9.49% in after-hours trading on Tuesday, following news of its upcoming satellite launches.
BHP Hedges China Risks With Olympic Dam Copper Investment
BHP invests over $556 million in copper projects at Olympic Dam, South Australia, to increase production and create jobs.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Senate confirmation of Trump nominee cements his shake-up of top civil rights agency
The Senate confirmed President Donald Trump's pick to fill a critical vacancy at the top agency for worker rights, restoring it to the full power needed to deepen his overhaul of civil rights enforcement.
Regeneron's Gene Therapy Shows Significant Gains In Genetic Hearing Loss
Regeneron gene therapy for OTOF-related hearing loss shows rapid, sustained improvements, including normal hearing in some participants.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
CCDOG Themed On 'Courage The Cowardly Dog' Explodes 86% After Joining 'Forces' With Shiba Inu
A memecoin based on the iconic “Courage the Cowardly Dog” cartoon figure soared Wednesday after being promoted by the Shiba Inu (CRYPTO: SHIB) ecosystem.
Cathie Wood's China Bet: Ark Buys Alibaba's AI Surge And Baidu's Autonomous Future, Dump's Stock Of Crypto-Pivot Brera
On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Baidu Inc. (NASDAQ:BIDU), Alibaba Group Holding Ltd.
If you're Reading This, There's Still Time - Ad
Figuring out how to generate enough energy to power AI will be one of our country's biggest problems - but one man believes "we'll be able to do it" thanks to this energy company.
The Big Mac That Cost $380,000: Why The Early Bitcoin Believer Who Paid 3.5 BTC For The Burger Has Zero Regrets
The story about the purchase of Papa John’s pizzas using Bitcoin (CRYPTO: BTC) is legendary, but did you know that someone also once paid for a Big Mac with the world’s largest cryptocurrency
Macron is set to appoint a new French prime minister in last-ditch move to tackle turmoil
PARIS (AP) — After a week of intense political turmoil, French President is set to appoint a new prime minister Friday in his latest bid to break the political deadlock that has gripped the country for more than a year, as France struggles with mounting economic challenges and ballooning debt.
Forget Tesla - This Is the Real Play - Ad
Elon just dropped $1B into Tesla shares. But the real money could be in his potential October 23 AI launch - and it's not Tesla.
When Bill Gates Questioned Lyft CEO Risher's Move To Jeff Bezos' 'Tiny, Little Internet Bookstore'—'Stupidest Decision' Ever
David Risher, current CEO of Lyft Inc recently shared a bold career move he made in 1996 that earned him a scathing rebuke from Bill Gates.
Nanobiotix-J&J Therapy Shows Promise In Tough Head And Neck Cancer
Nanobiotix reported updated Phase 1 trial data for JNJ-1900 in head and neck cancer, showing strong disease control and survival outcomes.
Could $1 Stock Be Sitting on a Billion-Dollar Discovery? - Ad
This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.
Taiwan Semiconductor Plans Ultra-Advanced Chips By 2028 With Massive Taichung Fab
Taiwan Semiconductor to build new 1.4nm fabrication plant in Taichung, expected to produce $16.49B annually.
Bitcoin Steady On $1 Billion ETF Inflows As XRP Dips Below $3 While Ethereum, Dogecoin Rise
Most cryptocurrencies are trading sideways on Tuesday morning, as the crypto Fear & Greed Index enters the Greed zone at 62.
Never Sell the Next Mag 7 Stocks! - Ad
A new set of 7 AI stocks are dominating the market. Here's why one financial guru says they could be the most famous companies in the world by 2030.
Ondas Holdings Stock Is Hitting New 52-Week Highs Today: Here's Why
Shares of Ondas Holdings Inc. (NASDAQ: ONDS) are soaring Thursday after the autonomous drone infrastructure company said it placed a significant purchase order.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.